Skip to content
A new market study predicts that the already booming animal biotech sector will grow by around 10% annually until the end of the decade. […]
Animal biotech expected to grow 10% annually, market research shows Read More »
The global nonprofit partnership CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is focused on supporting antibacterial research. Last week, CARB-X opened a call for
CARB-X’s call for proposals seeks to fill gaps in the global AMR pipeline Read More »
“Boosting with updated mRNA vaccines that target SARS-CoV-2 variants stimulates better neutralizing antibody responses than homologous boosters,” emerging evidence shows, according to a recently
Updated mRNA boosters stimulate better neutralizing antibody responses Read More »
The Biotechnology Innovation Organization (BIO), the world’s largest science and public advocacy organization for biotech companies, announced a leadership update and the appointment of
BIO announces leadership changes, interim CEO Read More »
According to a new observational study, there is a possible association between exposure to aluminum adjuvants in childhood vaccines and the development of persistent
CDC advises no change for vaccines with aluminum adjuvants Read More »
What is worse than getting COVID-19? How about getting COVID-19 and the flu at the same time? That is precisely the concern that health
Vaccines are the best defense against co-circulation of flu and COVID Read More »
Health and Human Services (HHS) Secretary Xavier Becerra is reportedly open to the idea of using the “march-in” provision of the Bayh-Dole Act to
HHS says march-in rights for drug price controls ‘not off the table’ Read More »
Today (October 10) is World Mental Health Day, on the heels of Mental Illness Awareness Week in the United States. This day is an
It’s World Mental Health Day – but mental health must be a priority every day Read More »
Pfizer Inc. announced on Wednesday it completed its nearly $5.4 billion acquisition of Global Blood Therapeutics, Inc. (GBT), the pioneer in treatments for sickle
Pfizer completes $5.4 billion acquisition of Global Blood Therapeutics Read More »
The market appears to be bullish on climate-related investments, even if threats of a downturn are chasing a lot of money toward safer, proven
Market stays bullish on innovative climate solutions Read More »
